REGULATION The international medical device industry is highly regulated.
Regulatory requirements are a major factor in determining whether substances and materials can be developed into marketable products and the amount of timeandexpense that shouldbe allotted tosuchdevelopment.
National regulatory authorities administer and enforce a complex series of laws and regulations that govern the testing, approval, manufacturing, labelling, marketing and sale of healthcare and pharmaceutical products.
They also review data supporting the safety and efficacy of such products.
Of particular importance is the requirement in many countries that products be authorised or registered prior to manufacture, marketing or sale and that such authorisation or registration be subsequently maintained.
The major regulatory agencies for Smith & Nephews products are the FDA in the US, the Medicines and Healthcare products Regulatory Agency in the UK and the Ministry for Health Labour and Welfare in Japan.
Payment for many medical device products is governed by reimbursementtariff .
The trend in recent years has been towards greater regulation and higher standards of technical appraisal, which generally entail lengthy inspections for compliance with appropriate standards, including regulations such as good manufacturing practices.
The Group believes that these recent changes will not have a material adverse effect on the Groups financial conditionand the results of operations.
All significant facilities within the Group are subject to regular internal audit for medical device regulatory compliance with national and Group standards and policies.
Management believes that the Groups operations currently comply in all material respects with applicable environmental laws and regulations.
Althoughthe Group continuesto make capital expenditure for environmental compliance, it is not currentlyaware of any  that wouldbe required as a result ofsuchlaws andregulationsthat  .
